The Jockey Club Releases Industry Initiatives Impact Report

The Jockey Club has released its 2024 Industry Impact Report. The report, which has traditionally been released at The Jockey Club's annual Round Table Conference in August, details how at least $7 million will be used in the coming year to support initiatives ranging from equine safety and aftercare to industry promotion and national and international collaboration, according to a Tuesday press release from the organization.

“The initiatives supported by The Jockey Club, together with others or wholly backed by The Jockey Club, have increased substantially in the last decade and a half,” said James Gagliano, president and COO, The Jockey Club. “They reflect the commitment by the board of stewards to invest our profits into a wide array of projects and activities that may serve as catalysts for growth of the sport and for ensuring the safety and welfare of its participants.”

The Jockey Club, a non-profit organization, has created a group of for-profit subsidiaries and partnerships, including the The Jockey Club Information Systems (TJCIS), InCompass Solutions, Equibase Company, and The Jockey Club Technology Services (TJCTS). These companies provide the industry with technology services and products and the profits they create are dispersed to The Jockey Club for investment back into the sport.

The Jockey Club supports two charities: the Grayson-Jockey Club Research Foundation and the The Jockey Club Safety Net Foundation.

Other Jockey Club initiatives include the multi-media fan development platform, American's Best Racing, while its aftercare efforts include support of the Thoroughbred Aftercare Alliance, as well as the Jockey Club Thoroughbred Incentive Program.

According to the impact report, The Jockey Club's 2024 investments in racing include over $3.5 million in industry growth initiatives and over $1.5 million in aftercare initiatives.

The post The Jockey Club Releases Industry Initiatives Impact Report appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Grayson-Jockey Club Approves Funding for EHV-1 and EHM Vaccine Research

The Grayson-Jockey Club Research Foundation recently issued a special call for research proposals to address vaccines for Equid Alphaherpesvirus 1 (EHV-1) and Equine Herpesvirus Myeloencephalopathy (EHM) and after a thorough review process by the foundation's veterinarian advisory committee, two research proposals were selected for funding.

The projects, led by Gisela Soboll Hussey of Michigan State University and Bettina Wagner of Cornell University, aim to develop novel nucleic acid vaccines to protect horses from EHV-1/EHM and EHV-4.

Soboll Hussey's project is titled, “Use of nucleic acid vaccines to protect from EHV-1/EHM,” and it will last three years. Her objective is to develop a novel mRNA-based EHV vaccine that protects horses from EHV-1 myeloencephalopathy, a method that will likely cross-protect horses against other types of equine herpesviruses. Wagner's project, titled, “A novel DNA vaccine platform to control EHV-1 and EHV-4,” will span two years and aims to develop an effective DNA vaccine for EHV-1 to protect horses against infection and disease, working to prevent catastrophic EHV outbreaks in the future.

The EHV-1 and EHM viruses affect horses of every breed and discipline, and they continue to cause significant economic losses through closures of racetracks and sales barns, delays in training schedules, and severe disease and death of horses. Total funding for the projects of $1,885,436 was provided by special donor Dr. John Ballantyne and Fargo-Moorhead Area Foundation.

“The work of our research advisory committee is timely and essential,” Dell Hancock, chairman of the Grayson-Jockey Club Research Foundation, said. “We look forward to working with these institutions to develop these vaccines and protect the equine industry from the devastating effects of EHV-1 and EHM.”

The post Grayson-Jockey Club Approves Funding for EHV-1 and EHM Vaccine Research appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Grayson-Jockey Club Research Foundation Approves 2023 Funding

The Grayson-Jockey Club Research Foundation has authorized expenditure of $1,498,077 to fund 12 new projects and nine continuing projects at 13 universities, as well as two career development awards in the coming year. The 2023 slate of research brings Grayson's totals to more than $34.1 million to underwrite 426 projects at 45 universities since 1983.

“The Grayson Foundation is dedicated to tackling a variety of equine health challenges, which is clearly reflected in our selected projects for this year,” said Jamie Haydon, president of Grayson. “Our research projects and career development awards wouldn't be possible without the kindness of our donors, and we thank them for their understanding of the significance of equine veterinary research.”

Details on the new projects are available here.

The post Grayson-Jockey Club Research Foundation Approves 2023 Funding appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Study: Horses On Lasix At Increased Risk of ‘Sudden Death’

A new study published this week in the Journal of the American Veterinary Medical Association and funded by the Grayson Jockey Club Foundation, has found that horses racing on Lasix were 62% more likely to die within three days of racing than were horses running without the diuretic.

Fatalities due to catastrophic musculoskeletal injury were not included in the study.

The use of Lasix was one of 15 risk factors identified in the report.

The study, relying on information from the Equine Injury Database, examined starts made by 284,387 Thoroughbreds at 144 racetracks in the U.S. and Canada from 2009 to 2021. A total of 4,198,073 starts were included in the study, which was conducted by Dr. Euan Bennet and Dr. Tim Parkin. The number of starts equals 92.2% of all races in North America run during the period of the study.

Among the starters, there were 536 instances where a horse died within the three-day window after racing, a rate of  0.13 per 1,000 starts.

Horses falling into the “sudden death” category had to have died within three days of racing and have had one or more of five fatal injury descriptions:  (1) sudden death (recorded as “SUD” in the EID); (2) pulmonary hemorrhage; (3) exercise-induced pulmonary hemorrhage (EIPH); (4) postexertional distress/heatstroke (PED); and (5) cardiac arrhythmia.

The study included 233,276 starts made by horses without Lasix. Eighteen or 0.08 per 1,000 starters died within three days. There were 3,964,797 starters who ran with Lasix and the result was 518 sudden deaths or 0.13 per 1000 starters. Ninety-four percent of all horses in the study raced with Lasix.

“…it could be hypothesized that furosemide administration in horses may increase the risk of sudden death through fatal arrhythmogenesis,” the study reads. “However, as the exact cause of sudden death (cardiac vs non-cardiac) was not determined for the horses of this study, we can only speculate at possible mechanisms. Further investigation is required to understand which, if any, pathophysiologic mechanisms could underlie the association between furosemide use and sudden death, as this finding raises further concerns about the ethics of race-day administration.”

The researchers also concluded: “…identifying any potential causal link between furosemide administration and sudden death should be a priority.”

The study looked at 49 risk factors and concluded that 15 of those factors could have led to a horse dying following a race. The list includes:

(*) Horses racing in the winter were at a 28% reduced risk of dying when compared to horses racing in the summer;

(*) There were fewer fatalities in longer races. In races contested at a mile or longer horses were 32% less likely to die than horses competing in races at six furlongs or shorter;

(*) Older horses were more likely to die than younger ones. Horses five or over were 44% more likely to die than horses who were three or younger;

(*) Horses that had been racing frequently were less likely to die than horses who had their races spaced out. For each additional race start made in the previous 0 to 30 days, individual horses were at reduced risk of sudden death. Horses that had made two or more race starts in the period 90 to 180 days before the current race were at 19% decreased risk of fatality compared to horses that had made 0 or 1 start in the same time period;

(*) Horses racing for the first time in a claiming race were at an increased risk. They were at 38% increased odds of sudden death compared to horses that were not making their debut in the claiming ranks;

(*) Horses that had previously been on a vet list, were 31% more likely to die compared to horses than had never been on a vet list;

(*) Horses whose last starts were made on a synthetic track were at 33% reduced odds of sudden death compared to starts made on dirt tracks;

The researchers hoped their information could lead to fewer sudden deaths.

The study reads: “Further work is required to determine which, if any, clinical signs are potential indicators and, indeed, whether such a rare outcome could be reliably predicted. The thoughtful application of big data predictive modeling would be helpful here; routine biometric monitoring of racehorses throughout their training and racing careers could provide valuable insights into horses' physical well-being.”

The post Study: Horses On Lasix At Increased Risk of ‘Sudden Death’ appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights